CircRNAs in anticancer drug resistance: recent advances and future potential
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CircRNAs in anticancer drug resistance: recent advances and future potential
Authors
Keywords
-
Journal
Molecular Cancer
Volume 19, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-08-17
DOI
10.1186/s12943-020-01240-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A novel circular RNA circFN1 enhances cisplatin resistance in gastric cancer via sponging miR‐182‐5p
- (2020) Xiao‐xu Huang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Hsa_circ_001680 affects the proliferation and migration of CRC and mediates its chemoresistance by regulating BMI1 through miR-340
- (2020) Xiangyu Jian et al. Molecular Cancer
- Circular RNA CRIM1 functions as a ceRNA to promote nasopharyngeal carcinoma metastasis and docetaxel chemoresistance through upregulating FOXQ1
- (2020) Xiaohong Hong et al. Molecular Cancer
- Predictive biomarkers and mechanisms underlying resistance to PD1/PD-L1 blockade cancer immunotherapy
- (2020) Daixi Ren et al. Molecular Cancer
- Exosome‐delivered circRNA promotes glycolysis to induce chemoresistance through the miR‐122‐PKM2 axis in colorectal cancer
- (2020) Xinyi Wang et al. Molecular Oncology
- CircPVT1 contributes to chemotherapy resistance of lung adenocarcinoma through miR-145-5p/ABCC1 axis
- (2020) Fushuang Zheng et al. BIOMEDICINE & PHARMACOTHERAPY
- Functions and mechanisms of circular RNAs in cancer radiotherapy and chemotherapy resistance
- (2020) Chaochu Cui et al. Molecular Cancer
- LncRNA UCA1 Induces Acquired Resistance to Gefitinib by Epigenetically Silencing CDKN1A Expression in Non-small-Cell Lung Cancer
- (2020) Tianwei Xu et al. Frontiers in Oncology
- Manuscript Template: Current perspectives in the application of medicinal plants against cancer: novel therapeutic agents Running Title: Medicinal plants as anticancer agents
- (2019) Sevgi Gezici et al. Anti-Cancer Agents in Medicinal Chemistry
- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The novel roles of circRNAs in human cancer
- (2019) Qingfeng Shang et al. Molecular Cancer
- Analyzing the interactions of mRNAs, miRNAs, lncRNAs and circRNAs to predict competing endogenous RNA networks in osteosarcoma chemo-resistance
- (2019) Kun-Peng Zhu et al. MOLECULAR THERAPY
- Association of BER and NER pathway polymorphism haplotypes and micronucleus frequencies with global DNA methylation in benzene-exposed workers of China
- (2019) Guang-hui Zhang et al. MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS
- Comprehensive analysis of circular RNA profiling in AZD9291‐resistant non‐small cell lung cancer cell lines
- (2019) Tianxiang Chen et al. Thoracic Cancer
- Circular RNA circ-DONSON facilitates gastric cancer growth and invasion via NURF complex dependent activation of transcription factor SOX4
- (2019) Lixian Ding et al. Molecular Cancer
- hsa_circ_0081143 promotes cisplatin resistance in gastric cancer by targeting miR-646/CDK6 pathway
- (2019) Minghui Xue et al. Cancer Cell International
- Circular RNA hsa_circ_0001649 inhibits hepatocellular carcinoma progression via multiple miRNAs sponge
- (2019) Yang Su et al. Aging-US
- TET1 promotes 5hmC-dependent stemness, and inhibits a 5hmC-independent epithelial-mesenchymal transition, in cervical precancerous lesions
- (2019) Po-Hsuan Su et al. CANCER LETTERS
- Mobilization of CD8+ T Cells via CXCR4 Blockade Facilitates PD-1 Checkpoint Therapy in Human Pancreatic Cancer
- (2019) Yongwoo David Seo et al. CLINICAL CANCER RESEARCH
- Circular RNA AKT3 upregulates PIK3R1 to enhance cisplatin resistance in gastric cancer via miR-198 suppression
- (2019) Xiaoxu Huang et al. Molecular Cancer
- Circular RNAs in Cancer: emerging functions in hallmarks, stemness, resistance and roles as potential biomarkers
- (2019) Min Su et al. Molecular Cancer
- circRNA_0025202 Regulates Tamoxifen Sensitivity and Tumor Progression via Regulating the miR-182-5p/FOXO3a Axis in Breast Cancer
- (2019) Yuting Sang et al. MOLECULAR THERAPY
- Hsa_circ_0003998 Promotes Chemoresistance via Modulation of miR-326 in Lung Adenocarcinoma Cells
- (2019) Wanjun Yu et al. ONCOLOGY RESEARCH
- Identification of differentially expressed circular RNAs in chemoresistant colorectal cancer
- (2019) Nadiah Abu et al. Epigenomics
- CircRNA_0025202 regulates tamoxifen sensitivity and tumor progression via regulating the miR-182-5p/FOXO3a axis in breast cancer
- (2019) Yuting Sang et al. Molecular Therapy-Nucleic Acids
- Circular RNAs and RNA Splice Variants as Biomarkers for Prognosis and Therapeutic Response in the Liquid Biopsies of Lung Cancer Patients
- (2019) Florence de Fraipont et al. Frontiers in Genetics
- Mechanisms of doxorubicin-induced drug resistance and drug resistant tumour growth in a murine breast tumour model
- (2019) Claudia Christowitz et al. BMC CANCER
- HOX transcript antisense RNA (HOTAIR) in cancer
- (2019) Xiaohan Qu et al. CANCER LETTERS
- Circular RNAs are differentially expressed in prostate cancer and are potentially associated with resistance to enzalutamide
- (2019) John Greene et al. Scientific Reports
- Circular RNA profiling identified as a biomarker for predicting the efficacy of Gefitinib therapy for non-small cell lung cancer
- (2019) Yu-Tao Liu et al. Journal of Thoracic Disease
- Circular RNAs in Cancer
- (2019) Duc-Hiep Bach et al. Molecular Therapy-Nucleic Acids
- Circular RNA Cdr1as upregulates SCAI to suppress cisplatin resistance in Ovarian Cancer via miR-1270 suppression
- (2019) Zhao Zhao et al. Molecular Therapy-Nucleic Acids
- The circRNA circPTPRA suppresses epithelial-mesenchymal transitioning and metastasis of NSCLC cells by sponging miR-96-5p
- (2019) Siliang Wei et al. EBioMedicine
- Hsa_circ_0001946 Inhibits Lung Cancer Progression and Mediates Cisplatin Sensitivity in Non-small Cell Lung Cancer via the Nucleotide Excision Repair Signaling Pathway
- (2019) Ma-Sha Huang et al. Frontiers in Oncology
- Targeting STAT3 inhibition to reverse cisplatin resistance
- (2019) Chao-Yue Sun et al. BIOMEDICINE & PHARMACOTHERAPY
- Resistance mechanisms to osimertinib in EGFR-mutated non-small cell lung cancer
- (2019) Alessandro Leonetti et al. BRITISH JOURNAL OF CANCER
- Immune checkpoint inhibitors of PD-L1 as cancer therapeutics
- (2019) Akintunde Akinleye et al. Journal of Hematology & Oncology
- Breast Cancer Risk–Associated SNPs in the mTOR Promoter Form De Novo KLF5- and ZEB1-Binding Sites that Influence the Cellular Response to Paclitaxel
- (2019) Qiuchen Chen et al. MOLECULAR CANCER RESEARCH
- The biogenesis, biology and characterization of circular RNAs
- (2019) Lasse S. Kristensen et al. NATURE REVIEWS GENETICS
- Circular RNAs add diversity to androgen receptor isoform repertoire in castration-resistant prostate cancer
- (2019) Subing Cao et al. ONCOGENE
- circKDM4C suppresses tumor progression and attenuates doxorubicin resistance by regulating miR-548p/PBLD axis in breast cancer
- (2019) Yiran Liang et al. ONCOGENE
- Effective targeted therapy based on dynamic monitoring of gene mutations in non-small cell lung cancer
- (2019) Tan Deng et al. Translational Lung Cancer Research
- Hsa_circ_0035483 sponges hsa-miR-335 to promote the gemcitabine-resistance of human renal cancer cells by autophagy regulation
- (2019) Lei Yan et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Maternally expressed gene 3 (MEG3): A tumor suppressor long non coding RNA
- (2019) Soudeh Ghafouri-Fard et al. BIOMEDICINE & PHARMACOTHERAPY
- The Role of Non-coding RNAs in Oncology
- (2019) Frank J. Slack et al. CELL
- SDF-1/CXCR4 axis facilitates myeloid-derived suppressor cells accumulation in osteosarcoma microenvironment and blunts the response to anti-PD-1 therapy
- (2019) Kuo Jiang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- The circ_0021977/miR‐10b‐5p/P21 and P53 regulatory axis suppresses proliferation, migration, and invasion in colorectal cancer
- (2019) Chen Lu et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Colorectal cancer
- (2019) Evelien Dekker et al. LANCET
- A view on drug resistance in cancer
- (2019) Neil Vasan et al. NATURE
- Extracellular Vesicle-derived circular RNAs confers chemoresistance in Colorectal cancer
- (2019) Kha Wai Hon et al. Scientific Reports
- CircRNA-UCK2 increased TET1 inhibits proliferation and invasion of prostate cancer cells via sponge miRNA-767-5p
- (2019) Zhendong Xiang et al. Open Medicine
- FoxO3a as a Positive Prognostic Marker and a Therapeutic Target in Tamoxifen-Resistant Breast Cancer
- (2019) Michele Pellegrino et al. Cancers
- Posttranscriptional regulation of AKT by circular RNA angiomotin- like 1 mediates chemoresistance against paclitaxel in breast cancer cells
- (2019) Jian Ma et al. Aging-US
- Circular RNA circ-PVT1 contributes to paclitaxel resistance of gastric cancer cells through regulates ZEB1 expression by sponging miR-124-3p
- (2019) Yan-yan Liu et al. BIOSCIENCE REPORTS
- Circ_0076305 regulates cisplatin resistance of non-small cell lung cancer via positively modulating STAT3 by sponging miR-296–5p
- (2019) Yu Dong et al. LIFE SCIENCES
- Circular RNAs: The star molecules in cancer
- (2019) Jianhong Liu et al. MOLECULAR ASPECTS OF MEDICINE
- Circular RNA circFGFR1 promotes progression and anti-PD-1 resistance by sponging miR-381-3p in non-small cell lung cancer cells
- (2019) Peng-Fei Zhang et al. Molecular Cancer
- Hsa_circ_0002483 inhibited the progression and enhanced the Taxol sensitivity of non-small cell lung cancer by targeting miR-182-5p
- (2019) Xiaoping Li et al. Cell Death & Disease
- circCELSR1 (hsa_circ_0063809) Contributes to Paclitaxel Resistance of Ovarian Cancer Cells by Regulating FOXR2 Expression via miR-1252
- (2019) Shu Zhang et al. Molecular Therapy-Nucleic Acids
- WNT Signaling in Tumors: The Way to Evade Drugs and Immunity
- (2019) Elena Martin-Orozco et al. Frontiers in Immunology
- MiR-326: Promising Biomarker for Cancer
- (2019) Yaojie Pan et al. Cancer Management and Research
- circFADS2 regulates lung cancer cells proliferation and invasion via acting as a sponge of miR-498
- (2018) Fucheng Zhao et al. BIOSCIENCE REPORTS
- Consolidation systemic treatment after radiochemotherapy for unresectable stage III non-small cell lung cancer
- (2018) Marcin Skrzypski et al. CANCER TREATMENT REVIEWS
- Mechanisms of resistance in estrogen receptor positive breast cancer: overcoming resistance to tamoxifen/aromatase inhibitors
- (2018) Jamie N Mills et al. CURRENT OPINION IN PHARMACOLOGY
- Overexpressed circPVT1, a potential new circular RNA biomarker, contributes to doxorubicin and cisplatin resistance of osteosarcoma cells by regulating ABCB1
- (2018) Zhu Kun-Peng et al. International Journal of Biological Sciences
- Effect of resveratrol on doxorubicin resistance in breast neoplasm cells by modulating PI3K/Akt signaling pathway
- (2018) Ju-Min Chen et al. IUBMB LIFE
- Circular RNA circITGA7 inhibits colorectal cancer growth and metastasis by modulating the Ras pathway and upregulating transcription of its host gene ITGA7
- (2018) Xiaomin Li et al. JOURNAL OF PATHOLOGY
- Doxorubicin, mesenchymal stem cell toxicity and antitumour activity: implications for clinical use
- (2018) Mia Baxter-Holland et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- A novel protein encoded by the circular form of the SHPRH gene suppresses glioma tumorigenesis
- (2018) Maolei Zhang et al. ONCOGENE
- CircHIPK3 promotes colorectal cancer growth and metastasis by sponging miR-7
- (2018) Kaixuan Zeng et al. Cell Death & Disease
- circHIPK3 regulates cell proliferation and migration by sponging miR-124 and regulating AQP3 expression in hepatocellular carcinoma
- (2018) Genwen Chen et al. Cell Death & Disease
- Circular RNA Signature Predicts Gemcitabine Resistance of Pancreatic Ductal Adenocarcinoma
- (2018) Feng Shao et al. Frontiers in Pharmacology
- Bone health during endocrine therapy for cancer
- (2018) Tilman D Rachner et al. Lancet Diabetes & Endocrinology
- Loss of PDPK1 abrogates resistance to gemcitabine in label-retaining pancreatic cancer cells
- (2018) Dandan Li et al. BMC CANCER
- Profiles and Bioinformatics Analysis of Differentially Expressed Circrnas in Taxol-Resistant Non-Small Cell Lung Cancer Cells
- (2018) Ning Xu et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- A novel circulating hsa_circ_0081001 act as a potential biomarker for diagnosis and prognosis of osteosarcoma
- (2018) Zhu Kun-Peng et al. International Journal of Biological Sciences
- Long Non-Coding RNAs as New Master Regulators of Resistance to Systemic Treatments in Breast Cancer
- (2018) Alma Campos-Parra et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Regulatory network of circRNA–miRNA–mRNA contributes to the histological classification and disease progression in gastric cancer
- (2018) Jia Cheng et al. Journal of Translational Medicine
- Emerging function and potential diagnostic value of circular RNAs in cancer
- (2018) Xianglun Cui et al. Molecular Cancer
- The Biogenesis, Functions, and Challenges of Circular RNAs
- (2018) Xiang Li et al. MOLECULAR CELL
- Life, death and autophagy
- (2018) Johnna Doherty et al. NATURE CELL BIOLOGY
- Screening circular RNA related to chemotherapeutic resistance in osteosarcoma by RNA sequencing
- (2018) Zhu Kun-Peng et al. Epigenomics
- Circular RNA hsa_circ_0004015 regulates the proliferation, invasion, and TKI drug resistance of non-small cell lung cancer by miR-1183/PDPK1 signaling pathway
- (2018) You Zhou et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- CircBA9.3 supports the survival of leukaemic cells by up-regulating c-ABL1 or BCR-ABL1 protein levels
- (2018) Yuming Pan et al. BLOOD CELLS MOLECULES AND DISEASES
- Circular RNA circAGO2 drives cancer progression through facilitating HuR-repressed functions of AGO2-miRNA complexes
- (2018) Yajun Chen et al. CELL DEATH AND DIFFERENTIATION
- FLI1 Exonic Circular RNAs as a Novel Oncogenic Driver to Promote Tumor Metastasis in Small Cell Lung Cancer
- (2018) Lingyu Li et al. CLINICAL CANCER RESEARCH
- Crosstalk in cancer resistance and metastasis
- (2018) Saeed Norouzi et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Recent advances in medical management of hepatocellular carcinoma
- (2018) Kenji Ikeda HEPATOLOGY RESEARCH
- Circular RNA circNOL10 Inhibits Lung Cancer Development by Promoting SCLM1-Mediated Transcriptional Regulation of the Humanin Polypeptide Family
- (2018) Aruo Nan et al. Advanced Science
- CircPAN3 mediates drug resistance in acute myeloid leukemia through the miR-153-5p/miR-183-5p–XIAP axis
- (2018) Jin Shang et al. EXPERIMENTAL HEMATOLOGY
- Cyclin B1/CDK1-regulated mitochondrial bioenergetics in cell cycle progression and tumor resistance
- (2018) Bowen Xie et al. CANCER LETTERS
- Exosomes derived from human umbilical cord mesenchymal stromal cells deliver exogenous miR-145-5p to inhibit pancreatic ductal adenocarcinoma progression
- (2018) Yixuan Ding et al. CANCER LETTERS
- Circular RNA PVT1 acts as a competing endogenous RNA for miR-497 in promoting non-small cell lung cancer progression
- (2018) Si Qin et al. BIOMEDICINE & PHARMACOTHERAPY
- Epithelial-mesenchymal transition and cancer stem cell-like phenotype induced by Twist1 contribute to acquired resistance to irinotecan in colon cancer
- (2017) Yong Yang et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Targeting noncoding RNAs in disease
- (2017) Brian D. Adams et al. JOURNAL OF CLINICAL INVESTIGATION
- A map of human circular RNAs in clinically relevant tissues
- (2017) Philipp G. Maass et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Plasma circular RNA profiling of patients with gastric cancer and their droplet digital RT-PCR detection
- (2017) Tianwen Li et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Novel Role of FBXW7 Circular RNA in Repressing Glioma Tumorigenesis
- (2017) Yibing Yang et al. JNCI-Journal of the National Cancer Institute
- Circular RNA_LARP4 inhibits cell proliferation and invasion of gastric cancer by sponging miR-424-5p and regulating LATS1 expression
- (2017) Jing Zhang et al. Molecular Cancer
- Circular RNAs in human cancer
- (2017) Yumin Wang et al. Molecular Cancer
- EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
- (2017) Tsukasa Shibue et al. Nature Reviews Clinical Oncology
- MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
- (2017) Rajesha Rupaimoole et al. NATURE REVIEWS DRUG DISCOVERY
- Cancer immunotherapy — immune checkpoint blockade and associated endocrinopathies
- (2017) David J. Byun et al. Nature Reviews Endocrinology
- Circular RNAs in cancer: opportunities and challenges in the field
- (2017) L S Kristensen et al. ONCOGENE
- LncRNA HULC triggers autophagy via stabilizing Sirt1 and attenuates the chemosensitivity of HCC cells
- (2017) H Xiong et al. ONCOGENE
- FDA Approval Summary: Pembrolizumab for Treatment of Metastatic Non‐Small Cell Lung Cancer: First‐Line Therapy and Beyond
- (2017) Lee Pai‐Scherf et al. ONCOLOGIST
- Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1–targeted therapy in lung cancer patients
- (2017) Alice O. Kamphorst et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Loss of a mammalian circular RNA locus causes miRNA deregulation and affects brain function
- (2017) Monika Piwecka et al. SCIENCE
- Alternative mechanisms of miR-34a regulation in cancer
- (2017) Eva Slabáková et al. Cell Death & Disease
- Screening circular RNA related to chemotherapeutic resistance in breast cancer
- (2017) Danfeng Gao et al. Epigenomics
- Inhibition of ZEB1 leads to inversion of metastatic characteristics and restoration of paclitaxel sensitivity of chronic chemoresistant ovarian carcinoma cells
- (2017) Jun Sakata et al. Oncotarget
- Novel Role of FBXW7 Circular RNA in Repressing Glioma Tumorigenesis
- (2017) Yibing Yang et al. JNCI-Journal of the National Cancer Institute
- Chlamydia trachomatis Prevents Apoptosis Via Activation of PDPK1-MYC and Enhanced Mitochondrial Binding of Hexokinase II
- (2017) Munir A. Al-Zeer et al. EBioMedicine
- Optimal primary therapy of ovarian cancer: Table 1.
- (2016) M. A. Bookman ANNALS OF ONCOLOGY
- Paclitaxel plus bevacizumab or paclitaxel as first-line treatment for HER2-negative metastatic breast cancer in a multicenter national observational study
- (2016) S. Delaloge et al. ANNALS OF ONCOLOGY
- Tumor suppressor genes and their underlying interactions in paclitaxel resistance in cancer therapy
- (2016) Jia-Hui Xu et al. Cancer Cell International
- Platinum-based drugs: past, present and future
- (2016) Shahana Dilruba et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- EMT: 2016
- (2016) M. Angela Nieto et al. CELL
- New insights and evolving role of pegylated liposomal doxorubicin in cancer therapy
- (2016) Alberto A. Gabizon et al. DRUG RESISTANCE UPDATES
- Ubiquitin-specific protease 4 inhibits breast cancer cell growth through the upregulation of PDCD4
- (2016) Yang Li et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Bmi-1 regulates stem cell-like properties of gastric cancer cells via modulating miRNAs
- (2016) Xiaofeng Wang et al. Journal of Hematology & Oncology
- Bladder cancer
- (2016) Ashish M Kamat et al. LANCET
- Targeting the androgenic pathway in elderly patients with castration-resistant prostate cancer
- (2016) Giandomenico Roviello et al. MEDICINE
- Improving early diagnosis of symptomatic cancer
- (2016) Willie Hamilton et al. Nature Reviews Clinical Oncology
- FDA Approval Summary: Nivolumab for the Treatment of Metastatic Non-Small Cell Lung Cancer With Progression On or After Platinum-Based Chemotherapy
- (2016) Dickran Kazandjian et al. ONCOLOGIST
- EGFR as a Pharmacological Target in EGFR -Mutant Non-Small-Cell Lung Cancer: Where Do We Stand Now?
- (2016) E-->-E -->Ke et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Fluoropyrimidine-Induced Cardiotoxicity: Manifestations, Mechanisms, and Management
- (2016) Michael E. Layoun et al. Current Oncology Reports
- Long non-coding RNAs in anti-cancer drug resistance
- (2016) Qin-nan Chen et al. Oncotarget
- Dose-dense Paclitaxel in Advanced Ovarian Cancer
- (2015) A. Kumar et al. CLINICAL ONCOLOGY
- The Role of miR-21 in Cancer
- (2015) Susan R. Pfeffer et al. DRUG DEVELOPMENT RESEARCH
- Gemcitabine resistance in pancreatic ductal adenocarcinoma
- (2015) Yoav Binenbaum et al. DRUG RESISTANCE UPDATES
- Establishment and characterization of gemcitabine-resistant human cholangiocarcinoma cell lines with multidrug resistance and enhanced invasiveness
- (2015) WAREEPORN WATTANAWONGDON et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials
- (2015) LANCET
- AZD9291 in EGFR Inhibitor–Resistant Non–Small-Cell Lung Cancer
- (2015) Pasi A. Jänne et al. NEW ENGLAND JOURNAL OF MEDICINE
- miR-296-5p suppresses cell viability by directly targeting PLK1 in non-small cell lung cancer
- (2015) CHUN XU et al. ONCOLOGY REPORTS
- CircInteractome: A web tool for exploring circular RNAs and their interacting proteins and microRNAs
- (2015) Dawood B. Dudekula et al. RNA Biology
- Regulation of circRNA biogenesis
- (2015) Ling-Ling Chen et al. RNA Biology
- Irinotecan, a key chemotherapeutic drug for metastatic colorectal cancer
- (2015) Ken-ichi Fujita WORLD JOURNAL OF GASTROENTEROLOGY
- The oncogenic receptor ErbB2 modulates gemcitabine and irinotecan/SN-38 chemoresistance of human pancreatic cancer cells via hCNT1 transporter and multidrug-resistance associated protein MRP-2
- (2015) Nicolas Skrypek et al. Oncotarget
- Lapatinib increases motility of triple-negative breast cancer cells by decreasing miRNA-7 and inducing Raf-1/MAPK-dependent interleukin-6
- (2015) Yu-Chun Hsiao et al. Oncotarget
- Decreased expression of PBLD correlates with poor prognosis and functions as a tumor suppressor in human hepatocellular carcinoma
- (2015) Aimin Li et al. Oncotarget
- Alterations in Ovarian Cancer Cell Adhesion Drive Taxol Resistance by Increasing Microtubule Dynamics in a FAK-dependent Manner
- (2015) Daniel J. McGrail et al. Scientific Reports
- Involvement of FoxQ1 in NSCLC through regulating EMT and increasing chemosensitivity
- (2015) Jian Feng et al. Oncotarget
- MiR-224 promotes the chemoresistance of human lung adenocarcinoma cells to cisplatin via regulating G1/S transition and apoptosis by targeting p21WAF1/CIP1
- (2014) H Wang et al. BRITISH JOURNAL OF CANCER
- MicroRNA-7expression in colorectal cancer is associated with poor prognosis and regulates cetuximab sensitivity viaEGFRregulation
- (2014) Toshinaga Suto et al. CARCINOGENESIS
- Recent advances in osteosarcoma
- (2014) Sander M Botter et al. CURRENT OPINION IN PHARMACOLOGY
- Identification of the First Inhibitor of the GBP1:PIM1 Interaction. Implications for the Development of a New Class of Anticancer Agents against Paclitaxel Resistant Cancer Cells
- (2014) Mirko Andreoli et al. JOURNAL OF MEDICINAL CHEMISTRY
- Detecting and characterizing circular RNAs
- (2014) William R Jeck et al. NATURE BIOTECHNOLOGY
- Understanding nucleotide excision repair and its roles in cancer and ageing
- (2014) Jurgen A. Marteijn et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- MicroRNA-7 Inhibits Multiple Oncogenic Pathways to Suppress HER2Δ16 Mediated Breast Tumorigenesis and Reverse Trastuzumab Resistance
- (2014) Felicia C. Huynh et al. PLoS One
- Platinum anticancer drugs and photochemotherapeutic agents: recent advances and future developments
- (2014) Evyenia Shaili SCIENCE PROGRESS
- Molecular aspects of cancer cell resistance to chemotherapy
- (2013) Magali Rebucci et al. BIOCHEMICAL PHARMACOLOGY
- Analysis of Tumor Specimens at the Time of Acquired Resistance to EGFR-TKI Therapy in 155 Patients with EGFR-Mutant Lung Cancers
- (2013) H. A. Yu et al. CLINICAL CANCER RESEARCH
- Tumor suppressor gene Oxidored-nitro domain-containing protein 1 regulates nasopharyngeal cancer cell autophagy, metabolism, and apoptosis in vitro
- (2013) Wenjuan Li et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Signatures of mutational processes in human cancer
- (2013) Ludmil B. Alexandrov et al. NATURE
- Changes in circulating microRNAs after radiochemotherapy in head and neck cancer patients
- (2013) Isolde Summerer et al. Radiation Oncology
- Molecular Mechanism of Action of Microtubule-Stabilizing Anticancer Agents
- (2013) A. E. Prota et al. SCIENCE
- Correction: Cell-Type Specific Features of Circular RNA Expression
- (2013) Julia Salzman et al. PLoS Genetics
- MicroRNAs: Novel mediators of resistance to microtubule-targeting agents
- (2012) Arun Kanakkanthara et al. CANCER TREATMENT REVIEWS
- Chemoradiation in anaplastic thyroid carcinomas
- (2012) X.S. Sun et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Akt/mTOR signaling pathway is crucial for gemcitabine resistance induced by Annexin II in pancreatic cancer cells
- (2012) Shingo Kagawa et al. JOURNAL OF SURGICAL RESEARCH
- MicroRNA-21 (miR-21) expression promotes growth, metastasis, and chemo- or radioresistance in non-small cell lung cancer cells by targeting PTEN
- (2012) Zhi-Li Liu et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Landscape of transcription in human cells
- (2012) Sarah Djebali et al. NATURE
- miR-34c may protect lung cancer cells from paclitaxel-induced apoptosis
- (2012) S Catuogno et al. ONCOGENE
- The hallmarks of cancer
- (2012) Tony Gutschner et al. RNA Biology
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Prognostic significance of serum miRNA-21 expression in human non-small cell lung cancer
- (2011) Zhao-Xia Wang et al. JOURNAL OF SURGICAL ONCOLOGY
- Molecular mechanisms of cisplatin resistance
- (2011) L Galluzzi et al. ONCOGENE
- Bmi-1 Is a Crucial Regulator of Prostate Stem Cell Self-Renewal and Malignant Transformation
- (2010) Rita U. Lukacs et al. Cell Stem Cell
- Paclitaxel chemotherapy for the treatment of gastric cancer
- (2009) Junichi Sakamoto et al. Gastric Cancer
- Genotype-guided tamoxifen therapy: time to pause for reflection?
- (2009) Timothy L Lash et al. LANCET ONCOLOGY
- Triptolide sensitizes AML cells to TRAIL-induced apoptosis via decrease of XIAP and p53-mediated increase of DR5
- (2008) B. Z. Carter et al. BLOOD
- 5-Fluorouracil: Mechanisms of Resistance and Reversal Strategies
- (2008) Ning Zhang et al. MOLECULES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started